Drug stocks move higher in late trading - MarketWatch
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Mylan tries to fend off Teva with bigger bid for Perrigo - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva Pharmaceuticals - Wikipedia
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva Pharmaceutical TEVA Pivots Trading Plans and Risk Controls - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Dish Networks tumbles on subscriber loss, HBO woes; Cisco outlook in focus - MarketWatch
Israeli stocks rise; Brainsway, Ratio Oil off - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va. - MarketWatch
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical Settles Opioid Suit With West Virginia - MarketWatch
Teva Pharmaceutical TEVA Pivots Trading Plans and Risk Controls - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Scum of the earth': Opioid victims unload on Purdue Pharma owners - MarketWatch
Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va. - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes - MarketWatch
Opinion: Multinationals learn the limits of being big - MarketWatch
